R. Raupach

1.4k total citations
22 papers, 1.1k citations indexed

About

R. Raupach is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, R. Raupach has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 15 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in R. Raupach's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). R. Raupach is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (14 papers) and Liver Disease Diagnosis and Treatment (11 papers). R. Raupach collaborates with scholars based in Germany, United States and Poland. R. Raupach's co-authors include Heiner Wedemeyer, Michael P. Manns, Jérôme Schlué, Markus Cornberg, Karsten Wursthorn, Katja Deterding, Jerzy Jaroszewicz, Beatriz Calle Serrano, Birgit Bremer and C.–Thomas Bock and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

R. Raupach

22 papers receiving 1.1k citations

Peers

Countries citing papers authored by R. Raupach

Since Specialization

Citations

This map shows the geographic impact of R. Raupach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Raupach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Raupach more than expected).

Fields of papers citing papers by R. Raupach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Raupach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Raupach. The network helps show where R. Raupach may publish in the future.

Co-authorship network of co-authors of R. Raupach

This figure shows the co-authorship network connecting the top 25 collaborators of R. Raupach. A scholar is included among the top collaborators of R. Raupach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Raupach. R. Raupach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How to Interpret Borderline HCV Antibody Test Results: A Comparative Study Investigating Four Different Anti-HCV Assays 2014 ·Viral Immunology ·Benjamin Maasoumy, Birgit Bremer, R. Raupach, Patrick Lehmann, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer	6
2	High prevalence of hepatitis markers in immigrant populations 2014 ·European Journal of Gastroenterology & Hepatology ·Benjamin Heidrich, (unknown), (unknown), Jona T. Stahmeyer, (unknown), (unknown), R. Raupach, Birgit Bremer, Michael P. Manns, Heiner Wedemeyer, (unknown)	27
3	Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis 2014 ·PLoS ONE ·Sven Pischke, A. Gisa, Pothakamuri Venkata Suneetha, Steffen B. Wiegand, Richard Taubert, Jérôme Schlué, (unknown), Heike Bantel, R. Raupach, Birgit Bremer, (unknown), Reinhold Schmidt, Michael P. Manns, Kinan Rifai, Torsten Witte, Heiner Wedemeyer	56
4	1232 INCREASED HEV SEROPREVALENCE IN PATIENTS WITH AUTOIMMUNE HEPATITIS 2013 ·Journal of Hepatology ·Sven Pischke, A. Gisa, Torsten Witte, (unknown), Birgit Bremer, R. Raupach, Patrick Lehmann, (unknown), Heike Bantel, Richard Taubert, Elmar Jaeckel, (unknown), Markus Cornberg, (unknown), Michael P. Manns, Heiner Wedemeyer	7
5	Hepatitis C virus core antigen testing in liver and kidney transplant recipients 2013 ·Journal of Viral Hepatitis ·Benjamin Heidrich, Sven Pischke, Fabian Helfritz, Ingmar Mederacke, J. Kirschner, J. Schneider, R. Raupach, Elmar Jäckel, Hannelore Barg‐Hock, Frank Lehner, J. Klempnauer, Thomas von Hahn, Markus Cornberg, Michael P. Manns, Sandra Ciesek, Heiner Wedemeyer	22
6	Chronic Hepatitis E in Heart Transplant Recipients 2012 ·American Journal of Transplantation ·Sven Pischke, Penelope Stiefel, B Franz, Birgit Bremer, (unknown), Albert Heim, Tina Ganzenmueller, Jérôme Schlué, (unknown), R. Raupach, (unknown), (unknown), Richard Taubert, Axel Haverich, Michael P. Manns, Heiner Wedemeyer, Christoph Bara	129
7	HBeAg‐positive hepatitis delta: virological patterns and clinical long‐term outcome 2012 ·Liver International ·Benjamin Heidrich, Beatriz Calle Serrano, Ramazan Idılman, Gökhan Kabaçam, Birgit Bremer, R. Raupach, Fatih Oğuz Önder, Katja Deterding, (unknown), A Taranta, Hakan Bozkaya, Kalliopi Zachou, Hans L. Tillmann, Mithat Bozdayı, Michael P. Manns, Cihan Yurdaydın, Heiner Wedemeyer	45
8	987 HIGH PREVALENCE OF HEPATITIS MARKER IN IMMIGRANT POPULATIONS: A PROSPECTIVE MULTICENTER SCREENING APPROACH IN A REAL WORLD SETTING 2012 ·Journal of Hepatology ·Benjamin Heidrich, (unknown), (unknown), (unknown), (unknown), R. Raupach, (unknown), Birgit Bremer, M.P. Manns, Heiner Wedemeyer, (unknown)	2
9	Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum 2011 ·Journal of Clinical Virology ·Karsten Wursthorn, Jerzy Jaroszewicz, (unknown), (unknown), R. Raupach, Ingmar Mederacke, Markus Cornberg, Michael P. Manns, Heiner Wedemeyer	72
10	HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis 2011 ·Journal of Clinical Virology ·Ingmar Mederacke, Andrej Potthoff, Dirk Meyer‐Olson, Matthias Meier, R. Raupach, Michael P. Manns, Heiner Wedemeyer, Hans L. Tillmann	29
11	Hepatitis E: An Emerging Infectious Disease in Germany? 2011 ·Zeitschrift für Gastroenterologie ·Sven Pischke, Albert Heim, Birgit Bremer, R. Raupach, (unknown), Tina Ganzenmueller, (unknown), (unknown), (unknown), (unknown), Michael P. Manns, Heiner Wedemeyer	25
12	Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease 2011 ·Nephrology Dialysis Transplantation ·Ingmar Mederacke, Matthias Meier, (unknown), (unknown), R. Raupach, (unknown), Karsten Wursthorn, Andrej Potthoff, Giuseppe Colucci, M.P. Manns, Heiner Wedemeyer, Hans L. Tillmann	12
13	Chronic hepatitis E in hematopoietic stem cell transplant patients in a low‐endemic country? 2011 ·Transplant Infectious Disease ·Christian Koenecke, Sven Pischke, Albert Heim, (unknown), Birgit Bremer, R. Raupach, Stefanie Buchholz, Thomas F. Schulz, Michael P. Manns, Arnold Ganser, Heiner Wedemeyer	36
14	Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective 2010 ·Journal of Hepatology ·Jerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn, Katja Deterding, Jérôme Schlué, R. Raupach, Robert Flisiak, C.–Thomas Bock, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg	325
15	333 KINETICS OF HCV CORE ANTIGEN DURING ANTIVIRAL TREATMENT OF ACUTE AND CHRONIC HEPATITIS C AS DETERMINED BY A NOVEL CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY 2009 ·Journal of Hepatology ·Ingmar Mederacke, Sandra Ciesek, R. Raupach, Karsten Wursthorn, Katja Deterding, Eike Steinmann, Markus Cornberg, Elmar Jaeckel, M.P. Manns, Thomas Pietschmann, Hans L. Tillmann, Heiner Wedemeyer	3
16	Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients 2009 ·Liver Transplantation ·Sven Pischke, Pothakamuri Venkata Suneetha, Christine Baechlein, Hannelore Barg‐Hock, Albert Heim, Nassim Kamar, Jérôme Schlué, Christian P. Strassburg, Frank Lehner, R. Raupach, Birgit Bremer, (unknown), Markus Cornberg, Frauke Seehusen, Wolfgang Baumgaertner, J. Klempnauer, Jacques Izopet, Michael P. Manns, B. Grummer, Heiner Wedemeyer	149
17	Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay 2009 ·Journal of Clinical Virology ·Ingmar Mederacke, Heiner Wedemeyer, Sandra Ciesek, Eike Steinmann, R. Raupach, Karsten Wursthorn, Michael P. Manns, Hans L. Tillmann	66
18	Virological and clinical characteristics of delta hepatitis in Central Europe 2009 ·Journal of Viral Hepatitis ·Benjamin Heidrich, Katja Deterding, Hans L. Tillmann, R. Raupach, Michael P. Manns, Heiner Wedemeyer	73
19	364 HBsAg SERUM LEVELS ARE ASSOCIATED WITH THE PHASE OF HBV-INFECTION 2009 ·Journal of Hepatology ·Jerzy Jaroszewicz, (unknown), Katja Deterding, Karsten Wursthorn, R. Raupach, Michael P. Manns, Robert Flisiak, Heiner Wedemeyer, Markus Cornberg	1
20	35 HEPATITIS E AS A ZOONOSIS AND THE RELEVANCE FOR LIVER TRANSPLANT RECIPIENTS 2009 ·Journal of Hepatology ·Sven Pischke, Christine Baechlein, (unknown), R. Raupach, Jérôme Schlué, (unknown), Albert Heim, C.P. Strassburg, Michael P. Manns, B. Grummer, Heiner Wedemeyer	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact